FLG works with leading life sciences and healthcare companies, from seed stage to emerging to enterprise. These innovative players are highly focused around fundraising, dealmaking and carefully managing  their costs. Rapidly evolving biotech, pharma and medtech clients are typically less focused on generating revenue but have significant regulatory and reporting requirements.  These clients require continual fundraising through all phases of growth. Pharma clients also need to know their CFO understands the FDA’s approval path to commercial viability. And familiarity with some of the science behind a drug going to market and what constitutes the total available market for a drug are key. Managing a life science, pharma or medtech company successfully to exit, often through a strategic acquisition scenario, is also a critical skill set for a healthcare sector CFO.

 

Listen to Oculeve Founder, Michael Ackerman, talk about his experience working with FLG:

 

And tune into a fireside chat with Angion CEO, Dr. Jay Venkatesan and CFO and FLG partner Greg Curhan for their discussion about the unique challenges and opportunities posed launching Angion’s IPO in February 2021 in the midst of COVID-19.

10X Technologies, Inc. Diagnostics Interim CFO Private
Acer Therapeutics Biopharma Public
Adverum Biotechnologies, Inc. Biopharma Public
Aimmune Therapeutics Biopharma Interim CFO Private
Aktana Life Sciences
Aktiv Pharma Group Biopharma
Alpha Innotech Corporation Medtech Due Diligence Private
ALX Oncology Biopharma Interim CFO Public
Amunix Biopharma Interim CFO
Amyris, Inc. Biopharma Interim CFO Public
Angion Biomedica Corp. Biopharma Public
Antheia Biopharma Private
ArmaGen, Inc. Biopharma Interim CFO Private
Armetheon, Inc. Biopharma Interim CFO
Arsenal Biosciences, Inc. Biopharma Private
Auxogyn, Inc. Diagnostics Interim CFO Private
BAROnova, Inc. Medtech Permanent CFO Private
Benevenue Medical Medtech Permanent CFO
Bioasis Technolodgies, Inc. Biopharma Permanent CFO Public
Bridge to Life, Ltd Medical Devices
CancerIQ Medtech Private
Cardima, Inc. Medtech Interim CFO Public
Ciphergen Biosystems, Inc. Biopharma Interim CFO Public
ClarVista Medical Medtech Interim CFO Private
Clinical Solutions Diagnostics Financial Advisory Private
Commure Life Sciences
Connect Biopharma Biopharma Public
Connetics Corp. Biopharma Public
Cortexyme Biopharma Permanent CFO Public
Cutera, Inc. Medtech Public
DigiLens Medical Devices
DigiSight Technologies Healthcare Services Interim CFO
Elevation Oncology, Inc. Biopharma Interim CFO Public
EmbraceHer Health, Inc. Healthcare IT Director
EpiBiome, Inc. Biopharma Interim CFO Private
Farapulse Medtech Interim CFO Private
Five Prime Therapeutics, Inc. Biopharma Interim CFO Public
Genalyte, Inc. Medtech Interim CFO Private
Geneoscopy Medtech Private
Gentiae Clinical Research, Inc. Healthcare Services Interim CFO Private
GRAIL, Inc. Biopharma Interim CFO Private
Hansen Medical, Inc. Medtech Director
Healthline Networks, Inc. Healthcare Services Interim CFO Private
Human API Healthcare IT
Ingenuity Systems, Inc. Healthcare Services Permanent CFO Private
Inspyr Therapeutics, Inc. Biopharma CEO Public
iPerian, Inc. Biopharma Interim CFO Private
IRIDEX Corporation Medtech Interim CFO Public
JenaValve Medtech Financial Advisory Private
Kedalion Therapeutics, Inc. Medtech Private
Kezar Life Sciences Biopharma Interim CFO Private
Kyverna Therapeutics Biopharma Private
Lark Technologies Healthcare IT Interim CFO Private
LevitasBio Life Sciences
Lightning Bolt Solutions Healthcare IT Interim CFO Private
MediciNova, Inc. Biopharma Permanent CFO Public
Mission Bio Genomics
Myoscience, Inc. Medtech Interim CFO
Neurobiological Technologies, Inc. Biopharma Permanent CFO Public
Nuclea Biotechnologies, Inc. Diagnostics Interim CFO Private
Oculeve, Inc. Medtech
ONI Medtech Private
Oyster Point Pharma, Inc. Biopharma Private
Pacific Fertility Center Healthcare Services Permanent CFO Private
Pacific Pharmaceutical Services Healthcare Services Director Private
PaxVax Biopharma Permanent CFO
Perlegen Sciences, Inc. Biopharma Interim CFO Private
Pharmatech, Inc. Healthcare Services Permanent CFO Private
PhysioHealth, Inc. Healthcare Services Interim CFO Private
Proteome Sciences Biopharma Interim CFO Private
Prothena Biosciences Biopharma Interim CFO Public
QuantaLife, Inc. Diagnostics Permanent CFO Private
RAPT Therapeutics Biopharma Interim CFO Public
RenovoRx Biopharma Public
Retrotope, Inc. Biopharma Interim CFO Private
Rivus Pharmaceuticals Biopharma Interim CFO Private
Route 92 Medical, Inc. Medtech
Saluda Medical Life Sciences
Scanadu Medtech Interim CFO Private
Singulex, Inc. Diagnostics Permanent CFO Private
Soleno Therapeutics, Inc. Biopharma Permanent CFO Public
Summerville Senior Living, Inc. Healthcare Services Interim CFO Private
Tethys Bioscience, Inc. Biopharma Interim CFO Private
Tonic Solutions, Inc. Healthcare IT Private
True North Therapeutics Life Sciences Permanent CFO Private
Tunitas Therapeutics, Inc. Biopharma Interim CFO Private
Twist Bioscience Biopharma Interim CFO Private
Vaxart, Inc. Biopharma
Vera Therapeutics Biopharma Public
ViOptix, Inc. Medtech Interim CFO Private
Zehna Therapeutics, Inc Biopharma
Zephyr Health, Inc. Healthcare IT Permanent CFO Private
Related Case Studies:
What Our Life Sciences Clients Say

“When I agreed to join Hansen Medical, I knew we faced a multitude of challenges that had to be promptly addressed. As we evaluated the capital needs and cost structure of the company, I needed a CFO who could be a balanced and trusted business partner.  I needed someone to ensure my strategy was being implemented effectively, essentially an extension of me. Chris Lowe, my FLG partner, was immediately effective in guiding our financing strategy and implementing our cost reduction plans. The success of these programs allowed us to then pursue a strategic sale.  Our achievements could not have been done without FLG’s support.”

Cary Vance, CEO, Hansen Medical Inc.

“We were seeking consulting in our finance function for long-term planning, financing, and reporting. We hired Patrick Nugent at FLG and he couldn’t have been a better choice. Patrick was able to provide effective frameworks and best practices, leverage his network and expertise in the industry, and engage cross-functionally. As a CFO, you have lots of choices when you hire outside resources like we did at Mission Bio, but I would definitely recommend FLG for providing talent with strong strategic-thinking, expertise, thoroughness and the ability to engage as a true partner. I wouldn’t hesitate to hire from FLG Partners again for strategic support to our Finance team.”

Marcel Roche, CFO, Mission Bio

“I’ve had the fortunate opportunity  to work closely with Mark Murray of FLG Partners in a series of  four  successful venture backed -backed companies in Silicon Valley  over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis). I consider him to be the  consummate professional and invaluable  in providing state of the art financial management and strategic advising  for young rapidly growing  drug and medical device companies. Mark has a wealth of experience and considerable savvy in a variety of different situations and market conditions, whether it be in developing a strategic plan, raising capital, optimizing operations or helping identify and manage liquidity events. In my mind he is an absolute go-to thinker and do-er for any company looking to attract top level management talent.”

Mark S. Blumenkranz, CEO & Chairman, Kedalion Therapeutics